SNOA News & Events

Sonoma Pharmaceuticals announced that Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel has earned the National Rosacea Society Seal of Acceptance.

Reports Q2 revenue $5.6M vs. $3.6M last year. "We are thrilled to report the highest quarterly revenues in Sonoma's history - $5.6 million for the three months ended September 30, 2025," said Amy Trombly, CEO of Sonoma Pharmaceuticals. "This achievement reflects the exceptional work of our team in expanding our distribution network, launching new products, and obtaining key regulatory clearances. While we anticipate some quarterly fluctuations as we continue to grow, we expect Sonoma's overall trajectory to be strongly positive, with increasing adoption of our high-quality products by both consumers and healthcare providers and solidification of our position as the global leader in the HOCl industry."

Sonoma Pharmaceuticals announced the launch of a new HOCl wound cleanser manufactured by Sonoma for Medline Industries, LP. The product will be distributed by Medline into hospital systems, home healthcare and other healthcare channels across the United States. The collaboration between Sonoma and Medline, initiated in 2024, combines Sonoma's expertise in developing safe and effective HOCl-based solutions with Medline's extensive hospital and healthcare distribution network. The new product provides clinicians with an advanced wound cleansing solution designed to promote healing and reduce infection risk without damaging healthy tissue.

Sonoma Pharmaceuticals registered its manufacturing facility and listed its Microcyn-based facial spray under the FDA's Modernization of Cosmetics Regulation Act of 2022. The MoCRA registration expands Sonoma's regulatory footprint, enabling the Company to manufacture and commercialize Microcyn technology products as cosmetics in the United States. Sonoma's manufacturing facility is already FDA-registered as a medical device establishment, supporting Sonoma's portfolio of FDA 510(k)-cleared products across wound care, dermatology, eye care, podiatry, and animal health. The MoCRA registration builds on this foundation and provides Sonoma with increased access to the rapidly growing U.S. cosmetics and dermatology consumer markets.